Infiuss Health

Infiuss Health is a private digital health and healthtech company building AI-powered digital patient twin and clinical trial simulation software for life science and healthcare users. The company positions its platform as a way to improve randomized controlled trial design, participant recruitment, biospecimen sourcing, and real-world data use, with a particular emphasis on improving representation of African populations in research. Its current product messaging centers on "Probe," a clinical trial copilot and simulation environment that helps researchers model patient response, test protocol assumptions, and optimize trial planning before study launch. Infiuss Health appears to operate as a software and data platform business rather than a therapeutic drug developer, so it does not have a conventional biopharma pipeline of drug candidates. The company is backed by startup investors and accelerators including Y Combinator and 43North, and remains active as an independent private company.